Moxonidine (hydrochloride) (standaard)

Moxonidine hydrochloride (Standard) is the analytical standard of Moxonidine hydrochloride. This product is intended for research and analytical applications. Moxonidine (BDF5895) is an orally active imidazoline type 1 receptor (I1-R) agonist. Moxonidine activates imidazoline I1 receptors and α2 adrenoceptors, affecting oxidized low-density lipoprotein uptake. Moxonidine reduces atherosclerotic lesions and lowers blood pressure. Moxonidine can be used in the study of hypertension, heart failure, and atherosclerosis[1][2][3][4][5][6][7].

75536-04-8

12352100

Adrenergic Receptor; Imidazoline Receptor; LDLR; Reference Standards

GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling; Others

Neurological Disease; Cardiovascular Disease

CC1=NC(OC)=C(C(Cl)=N1)NC2=NCCN2.[H]Cl

C9H13Cl2N5O

278.14

[1]Aceros H, et al. Moxonidine modulates cytokine signalling and effects on cardiac cell viability. Eur J Pharmacol. 2014 Oct 5;740:168-82.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-B0374AR/

Reference Standards